Skip to main content
Top
Published in: Journal of Urban Health 2/2007

01-03-2007

Observed Patterns of Illicit Opiate Overdose Deaths in Chicago, 1999–2003

Authors: Greg Scott, Ph.D., Sandra D. Thomas, Harold A. Pollack, Bradley Ray

Published in: Journal of Urban Health | Issue 2/2007

Login to get access

Abstract

This article explores trends and correlates of Chicago’s opiate-related overdose (OD) deaths. We manually examined data from every death certificate filed between 1999 and 2003 to identify all Chicago residents’ accidental deaths involving acute intoxication with illicit opiates, OD, or opiate poisoning. The analysis includes an examination of contextual characteristics in 77 Chicago neighborhoods. Negative binomial regression analysis permits the calculation of incidence rate ratios (IRR) associated with time trends. OD incidence peaked in 2000 and then declined markedly by 2003 [year 2000–2003 IRR = 0.65, 95% confidence interval (CI) (0.54, 0.78)]. Over the 2000–2003 period, overall incidence of fatal OD declined by 34%. Over this period, the sharpest observed declines occurred among African-Americans [IRR = 0.64, 95% CI (0.51, 0.81)] and Hispanics/Latinos [IRR = 0.53, 95% CI (0.32, 0.88)]. The opiate-related fatality incidence also declined among non-Hispanic whites [IRR = 0.743, 95% CI (0.52, 1.06)]. Even at the end of the study period, illicit opiate-related OD accounted for 35% of all accidental deaths to Chicago adults aged 18–64, with 45% of OD deaths occurring among African-American men. In summary, illicit opiate OD in Chicago peaked in 2000 and markedly declined by 2003. Opiate OD continues to pose a major threat of mortality to Chicago adults.
Footnotes
1
For estimation purposes an “injection drug user” is defined as anyone who has injected any illicit substance (e.g., heroin, cocaine, crystal methamphetamine) at least once in the past year.
 
2
“Opiate-related” means that the postmortem toxicology report indicated illicit opiate poisoning/intoxication as a primary cause of death.
 
3
For example, the coding of multiple drug combination does not reveal the specific drugs involved.
 
4
The Social Science Research Committee at the University of Chicago established “community areas” in the late 1920s. A CA consists of an aggregation of census tracts with a collectively shared history and sociocultural public sphere. CA boundaries have remained stable over the past 75 years to allow for cross-time comparisons. The United States Census Bureau has officially sanctioned these areas and organizes Chicago’s census data by tract and by CA.
 
5
Naloxone is the generic version of Narcan®.
 
Literature
1.
go back to reference Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal heroin overdose. Addiction. 1996;91(3):405–411.PubMedCrossRef Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: I. Prevalence and correlates of non-fatal heroin overdose. Addiction. 1996;91(3):405–411.PubMedCrossRef
2.
go back to reference Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. Responses to overdose. Addiction. 1996;91(3):413–417.PubMedCrossRef Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. Responses to overdose. Addiction. 1996;91(3):413–417.PubMedCrossRef
3.
4.
go back to reference Chiasson M, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York City. J Acquir Immune Defic Syndr. 1999;21(1):59–64.PubMed Chiasson M, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York City. J Acquir Immune Defic Syndr. 1999;21(1):59–64.PubMed
5.
go back to reference Des Jarlais D, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003;157(5):467–471.PubMedCrossRef Des Jarlais D, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol. 2003;157(5):467–471.PubMedCrossRef
6.
go back to reference Barkan S, Leonetti A, Hopkins S, Duchin J. Substantial decrease in numbers and rates of AIDS deaths over the last decade [letter to the editor]. J Acquir Immune Defic Syndr. 1999;22(3):312–314.PubMed Barkan S, Leonetti A, Hopkins S, Duchin J. Substantial decrease in numbers and rates of AIDS deaths over the last decade [letter to the editor]. J Acquir Immune Defic Syndr. 1999;22(3):312–314.PubMed
7.
go back to reference Edlin B. Prevention and treatment of hepatitis C in injection drug users. Hepatology. 2002;36(5 (S1)):S210–219.CrossRef Edlin B. Prevention and treatment of hepatitis C in injection drug users. Hepatology. 2002;36(5 (S1)):S210–219.CrossRef
8.
go back to reference Lorvick J, Kral A, Seal K, Gee L, Edlin B. Prevalence and duration of hepatitis C among injection drug users in San Francisco, CA. Am J Public Health. 2001;91(1):46–47.PubMed Lorvick J, Kral A, Seal K, Gee L, Edlin B. Prevalence and duration of hepatitis C among injection drug users in San Francisco, CA. Am J Public Health. 2001;91(1):46–47.PubMed
9.
go back to reference Hagan H, McGough J, Thiede H, Weiss N, Hopkins S, Alexander E. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149(3):203–213.PubMed Hagan H, McGough J, Thiede H, Weiss N, Hopkins S, Alexander E. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol. 1999;149(3):203–213.PubMed
10.
go back to reference Thorpe L, Ouellet L, Levy J, Williams I, Monterroso E. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J Infect Dis. 2000;182(6):1588–1594.PubMedCrossRef Thorpe L, Ouellet L, Levy J, Williams I, Monterroso E. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997–1999. J Infect Dis. 2000;182(6):1588–1594.PubMedCrossRef
11.
go back to reference Thomas D, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore). 1995;74(4):212–220.CrossRef Thomas D, Vlahov D, Solomon L, et al. Correlates of hepatitis C virus infections among injection drug users. Medicine (Baltimore). 1995;74(4):212–220.CrossRef
12.
go back to reference Centers for Disease Control and Prevention. Heroin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morb Mortal Wkly Rep. 2000;49(28):633–636. Centers for Disease Control and Prevention. Heroin overdose deaths—Multnomah County, Oregon, 1993–1999. MMWR Morb Mortal Wkly Rep. 2000;49(28):633–636.
13.
go back to reference Centers for Disease Control and Prevention. Unintentional opiate overdose deaths—King County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49(28):636–640. Centers for Disease Control and Prevention. Unintentional opiate overdose deaths—King County, Washington, 1990–1999. MMWR Morb Mortal Wkly Rep. 2000;49(28):636–640.
14.
go back to reference Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. Br Med J. 1996;312(7044):1435–1436. Strang J, Darke S, Hall W, Farrell M, Ali R. Heroin overdose: the case for take-home naloxone. Br Med J. 1996;312(7044):1435–1436.
15.
go back to reference Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction. 1994;89(10):1299–1308.PubMedCrossRef Oppenheimer E, Tobutt C, Taylor C, Andrew T. Death and survival in a cohort of heroin addicts from London clinics: a 22-year follow-up study. Addiction. 1994;89(10):1299–1308.PubMedCrossRef
16.
go back to reference Barnett P. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction. 1999;94(4):479–488.PubMedCrossRef Barnett P. The cost-effectiveness of methadone maintenance as a health care intervention. Addiction. 1999;94(4):479–488.PubMedCrossRef
17.
go back to reference Hulse G, English D, Milne E, Holman C. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94(2):221–229.PubMedCrossRef Hulse G, English D, Milne E, Holman C. The quantification of mortality resulting from the regular use of illicit opiates. Addiction. 1999;94(2):221–229.PubMedCrossRef
18.
go back to reference Sporer K. Strategies for preventing heroin overdose. Br Med J. 2003;326(7386):442–444.CrossRef Sporer K. Strategies for preventing heroin overdose. Br Med J. 2003;326(7386):442–444.CrossRef
19.
go back to reference ACMD. Reducing Drug-related Deaths. London: Advisory Council on the Misuse of Drugs, Stationery Office; 2000. ACMD. Reducing Drug-related Deaths. London: Advisory Council on the Misuse of Drugs, Stationery Office; 2000.
20.
go back to reference Donoghoe M. Opioid Overdose. Trends, Risk Factors and Priorities for Action. Geneva: World Health Organization; 1998. Donoghoe M. Opioid Overdose. Trends, Risk Factors and Priorities for Action. Geneva: World Health Organization; 1998.
21.
go back to reference Sporer K. Acute heroin overdose. Ann Intern Med. 1999;130(7):584–590.PubMed Sporer K. Acute heroin overdose. Ann Intern Med. 1999;130(7):584–590.PubMed
22.
go back to reference Garfield J, Drucker E. Fatal overdose trends in major U.S. cities: 1990–1997. Addict Res Theory. 2001;9(5):425–436. Garfield J, Drucker E. Fatal overdose trends in major U.S. cities: 1990–1997. Addict Res Theory. 2001;9(5):425–436.
23.
go back to reference Holmberg S. The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. Am J Public Health. 1996;86(5):642–654.PubMed Holmberg S. The estimated prevalence and incidence of HIV in 96 large U.S. metropolitan areas. Am J Public Health. 1996;86(5):642–654.PubMed
24.
go back to reference Friedman S, Tempalski B, Cooper H, et al. Estimating numbers of injection drug users in metropolitan areas for structural analysis of community vulnerability and for assessing relative degrees of service provision for injection drug users. J Urban Health. 2004;81(3):377–400.PubMed Friedman S, Tempalski B, Cooper H, et al. Estimating numbers of injection drug users in metropolitan areas for structural analysis of community vulnerability and for assessing relative degrees of service provision for injection drug users. J Urban Health. 2004;81(3):377–400.PubMed
25.
go back to reference Scott G. Estimating Injection Drug User Population Parameters in Chicago: A Review and Synthesis of Secondary Data for the National HIV Behavioral Surveillance Effort; October 2004. Atlanta: Centers for Disease Control and Prevention; 2005. Scott G. Estimating Injection Drug User Population Parameters in Chicago: A Review and Synthesis of Secondary Data for the National HIV Behavioral Surveillance Effort; October 2004. Atlanta: Centers for Disease Control and Prevention; 2005.
26.
go back to reference Scott G. Ethnographic Assessment of Injection Drug Use in Chicago: A Foundation for Behavioral Surveillance; January 2005. Atlanta: Centers for Disease Control and Prevention; 2005. Scott G. Ethnographic Assessment of Injection Drug Use in Chicago: A Foundation for Behavioral Surveillance; January 2005. Atlanta: Centers for Disease Control and Prevention; 2005.
27.
go back to reference Kane-Willis K, Schmitz-Bechteler S. A Multiple Indicator Analysis of Heroin Use in the Chicago Metropolitan Area: 1995 to 2002. Chicago, IL: Roosevelt University; 2004. Kane-Willis K, Schmitz-Bechteler S. A Multiple Indicator Analysis of Heroin Use in the Chicago Metropolitan Area: 1995 to 2002. Chicago, IL: Roosevelt University; 2004.
28.
go back to reference Steentoft A, Teige B, Holmgren P, et al. Fatal poisonings in young drug addicts in the Nordic countries: a comparison between 1984–1985 and 1991. Forensic Sci Int. 1996;78(1):29–37.PubMedCrossRef Steentoft A, Teige B, Holmgren P, et al. Fatal poisonings in young drug addicts in the Nordic countries: a comparison between 1984–1985 and 1991. Forensic Sci Int. 1996;78(1):29–37.PubMedCrossRef
29.
go back to reference EMCDDA. 2000 Annual Report on the State of the Drugs Problem in the European Union. Madrid: European Monitoring Centre for Drugs and Drug Addiction; 2000. EMCDDA. 2000 Annual Report on the State of the Drugs Problem in the European Union. Madrid: European Monitoring Centre for Drugs and Drug Addiction; 2000.
30.
go back to reference NIDA. NIDA Annual Emergency Room Data 1995: Data from the Drug Abuse Warning Network (DAWN). Washington, DC: Department of Health and Human Services; 1995. NIDA. NIDA Annual Emergency Room Data 1995: Data from the Drug Abuse Warning Network (DAWN). Washington, DC: Department of Health and Human Services; 1995.
31.
go back to reference Davidson P, McLean R, Kral A, Gleghorn A, Edlin B, Moss A. Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention. J Urban Health. 2003;80(2):261–273.PubMed Davidson P, McLean R, Kral A, Gleghorn A, Edlin B, Moss A. Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention. J Urban Health. 2003;80(2):261–273.PubMed
32.
go back to reference Goldberger B, Cone E, Grant T, Caplan T, Levine B, Smialek J. Disposition of heroin and its metabolites in heroin related deaths. J Anal Toxicol. 1994;18(1):22–28.PubMed Goldberger B, Cone E, Grant T, Caplan T, Levine B, Smialek J. Disposition of heroin and its metabolites in heroin related deaths. J Anal Toxicol. 1994;18(1):22–28.PubMed
33.
go back to reference Ruttenberger A, Luke J. Heroin-related deaths: a new epidemiological insights. Science. 1984;226(4670):14–20.CrossRef Ruttenberger A, Luke J. Heroin-related deaths: a new epidemiological insights. Science. 1984;226(4670):14–20.CrossRef
34.
go back to reference Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction. 2001;96(8):1113–1125.PubMedCrossRef Warner-Smith M, Darke S, Lynskey M, Hall W. Heroin overdose: causes and consequences. Addiction. 2001;96(8):1113–1125.PubMedCrossRef
35.
go back to reference Heinzmann D, DSadovi C, Maxwell T. Deadly Heroin Mix Tightens Grip on City. Chicago Tribune. June 7, 2006;A:1. Heinzmann D, DSadovi C, Maxwell T. Deadly Heroin Mix Tightens Grip on City. Chicago Tribune. June 7, 2006;A:1.
36.
go back to reference Cameron A, Trivedi P. Regression Analysis of Count Data. Cambridge, UK: Cambridge University Press; 1998. Cameron A, Trivedi P. Regression Analysis of Count Data. Cambridge, UK: Cambridge University Press; 1998.
37.
go back to reference Pollack H, Dombkowski K, Zimmerman J, et al. Emergency department use among Michigan children with special health care needs: an introductory study. Health Serv Res. 2004;39(3):665–692.PubMedCrossRef Pollack H, Dombkowski K, Zimmerman J, et al. Emergency department use among Michigan children with special health care needs: an introductory study. Health Serv Res. 2004;39(3):665–692.PubMedCrossRef
38.
go back to reference Pollack H, Khoshnood K, Blankenship K, Altice F. The impact of needle exchange-based health services on emergency department use. J Gen Intern Med. 2002;17(5):341–348.PubMedCrossRef Pollack H, Khoshnood K, Blankenship K, Altice F. The impact of needle exchange-based health services on emergency department use. J Gen Intern Med. 2002;17(5):341–348.PubMedCrossRef
39.
go back to reference Louria D, Hensle R, Rose J. The major medical complications of heroine addiction. Ann Intern Med. 1967;67(1):1–22.PubMed Louria D, Hensle R, Rose J. The major medical complications of heroine addiction. Ann Intern Med. 1967;67(1):1–22.PubMed
40.
go back to reference Degenhardt L, Day C, Gilmour S, Hall W. The “lessons” of the Australian “heroin shortage”. Subst Abuse Treat Prev Policy. 2006;1:11.PubMedCrossRef Degenhardt L, Day C, Gilmour S, Hall W. The “lessons” of the Australian “heroin shortage”. Subst Abuse Treat Prev Policy. 2006;1:11.PubMedCrossRef
41.
go back to reference Massey DS, Denton NA. American Apartheid: Segregation and the Making of the American Underclass. Cambridge, MA: Harvard University Press; 1993. Massey DS, Denton NA. American Apartheid: Segregation and the Making of the American Underclass. Cambridge, MA: Harvard University Press; 1993.
42.
go back to reference Venkatesh SA. American Project: The Rise and Fall of a Modern Ghetto. Cambridge, MA: Harvard University Press; 2000. Venkatesh SA. American Project: The Rise and Fall of a Modern Ghetto. Cambridge, MA: Harvard University Press; 2000.
43.
go back to reference Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95(5):687–695.PubMedCrossRef Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction. 2000;95(5):687–695.PubMedCrossRef
44.
go back to reference Drucker E. Harm reduction: a public health strategy. Curr Issues Public Health. 1995;1:64–70. Drucker E. Harm reduction: a public health strategy. Curr Issues Public Health. 1995;1:64–70.
45.
go back to reference Strang J, Best D, Man L, Noble A, Gossop M. Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation. Int J Drug Policy. 2000;11(6):437–445.PubMedCrossRef Strang J, Best D, Man L, Noble A, Gossop M. Peer-initiated overdose resuscitation: fellow drug users could be mobilised to implement resuscitation. Int J Drug Policy. 2000;11(6):437–445.PubMedCrossRef
46.
go back to reference Collins E, Kleber H, Whittington R, Heitler N. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. J Am Med Assoc. 2005;294(8):903–913.CrossRef Collins E, Kleber H, Whittington R, Heitler N. Anesthesia-assisted vs buprenorphine- or clonidine-assisted heroin detoxification and naltrexone induction: a randomized trial. J Am Med Assoc. 2005;294(8):903–913.CrossRef
47.
go back to reference Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively-injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89–96.PubMedCrossRef Maxwell S, Bigg D, Stanczykiewicz K, Carlberg-Racich S. Prescribing naloxone to actively-injecting heroin users: a program to reduce heroin overdose deaths. J Addict Dis. 2006;25(3):89–96.PubMedCrossRef
48.
go back to reference MacGillis A. City Seeks Expanded Anti-OD Training. Sun. September 27, 2005. MacGillis A. City Seeks Expanded Anti-OD Training. Sun. September 27, 2005.
49.
go back to reference Bennett G, Higgins D. Accidental overdose among injecting drug users in Dorset, UK. Addiction. 1999;94(8):1179–1190.PubMedCrossRef Bennett G, Higgins D. Accidental overdose among injecting drug users in Dorset, UK. Addiction. 1999;94(8):1179–1190.PubMedCrossRef
50.
go back to reference Caulkins J, Reuter P. Heroin supply in the long-term and short-term perspectives: comments on Wood et al. 2006. Addiction. 2006;101(5):621–622.PubMedCrossRef Caulkins J, Reuter P. Heroin supply in the long-term and short-term perspectives: comments on Wood et al. 2006. Addiction. 2006;101(5):621–622.PubMedCrossRef
51.
go back to reference Wood E, Stoltz J, Li K, Montaner J, Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction. 2006;101(5):689–695.PubMedCrossRef Wood E, Stoltz J, Li K, Montaner J, Kerr T. Changes in Canadian heroin supply coinciding with the Australian heroin shortage. Addiction. 2006;101(5):689–695.PubMedCrossRef
52.
go back to reference Community Epidemiology Working Group. Proceedings of the Community Epidemiology Work Group, volume II; June 2005. Community Epidemiology Work Group; 2005. Community Epidemiology Working Group. Proceedings of the Community Epidemiology Work Group, volume II; June 2005. Community Epidemiology Work Group; 2005.
53.
go back to reference Community Epidemiology Working Group, Proceedings of the Community Epidemiology Working Group, Volume II, January 2006. Community Epidemiology Working Group, Proceedings of the Community Epidemiology Working Group, Volume II, January 2006.
54.
go back to reference CDPH. Special Calculation, Chicago OD Mortality. Chicago: Chicago Department of Public Health; 2005. CDPH. Special Calculation, Chicago OD Mortality. Chicago: Chicago Department of Public Health; 2005.
55.
go back to reference Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend. 1999;54(2):155–161. Darke S, Hall W, Weatherburn D, Lind B. Fluctuations in heroin purity and the incidence of fatal heroin overdose. Drug Alcohol Depend. 1999;54(2):155–161.
Metadata
Title
Observed Patterns of Illicit Opiate Overdose Deaths in Chicago, 1999–2003
Authors
Greg Scott, Ph.D.
Sandra D. Thomas
Harold A. Pollack
Bradley Ray
Publication date
01-03-2007
Published in
Journal of Urban Health / Issue 2/2007
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-007-9157-7

Other articles of this Issue 2/2007

Journal of Urban Health 2/2007 Go to the issue